Apoptosis and autoimmunity

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 3, 1997, Pages 259-266

  Koh, Jason S ^a   Levine, Jerrold S ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1; CD4 ANTIGEN; CD8 ANTIGEN; CELL ANTIGEN; CELL SURFACE RECEPTOR; DEOXYRIBONUCLEASE I; DNA; DNA ANTIBODY; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; EPITOPE; FAS ANTIGEN; HISTONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LAMIN B; LAMIN C; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROTEIN KINASE; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNINDEXED DRUG; HLA ANTIGEN CLASS 2;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; DISEASE ASSOCIATION; DNA HISTONE INTERACTION; ETIOLOGY; GENE; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; GENETICS; IMMUNOLOGY; MOUSE; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MODELS, BIOLOGICAL; SELF TOLERANCE;

EID: 0031135405     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199705000-00011     Document Type: Article

References (68)

1. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456.
2. Mountz JD, Zhou T, Su X, Wu J, Cheng J: The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases. Clin Immunol Immunopathol 1996, 80(suppl):S2-S14.
3. Kotzin BL: Systemic lupus erythematosus. Cell 1996, 85:303-306.
4. Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell 1996, 85:311-318.
5. Mills JA: Systemic lupus erythematosus. New Engl J Med 1994, 330:1871-1879.
6. Jevnikar AM, Grusby MJ, Glimcher LH: Prevention of nephritis in major histocompatibility complex class II-deficient MRL-Ipr mice. J Exp Med 1994, 179:1137-1143.
7. + T cells but normal autoantibody production in Ipr/ Ipr mice lacking major histocompatibility complex class I molecules. Eur J Immunol 1995, 25:37-41. Elimination of MHC I expression in MRU/Ipr mice had no effect on severity of lupus nephritis or on levels of rheumatoid factor and anti-DNA autoantibodies.
8. Wofsy D, Seamen WE: Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 1985, 161:378-391.
9. + T cells to lymphoproliferation and autoantibody production in MRL-Ipr/Ipr mice. J Exp Med 1988, 167:1713-1718.
10. Koh D-R, Ho A, Rahemtulla A, Fung-Leung W-P, Griesser H, Mak T-W: Murine lupus in MRL/Ipr mice lacking CD4 or CD8 T cells. Eur J Immunol 1995, 25:2558-2562.
11. Chen S-Y, Takeoka Y, Ansari AA, Boyd R, Klinman DM, Gershwin ME: The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand black (NZB) mice. J Immunol 1996, 157:2676-2684.
12. Sobel ES, Cohen PL, Eisenberg RA: Ipr T cells are necessary for autoantibody production in Ipr mice. J Immunol 1993, 150:4160-4167.
13. Sobel ES, Kakkanaiah VN, Kakkanaiah M, Cheek RL, Cohen PL, Eisenberg RA: T-B collaboration for autoantibody production in Ipr mice is cognate and MHC-restricted. J Immunol 1994, 152:6011-6016.
14. Giese T, Davidson WF: Chronic treatment of C3H-Ipr/Ipr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J Immunol 1994, 152:2000-2010.
15. Peng SL, Madaio MP, Hughes DPM, Crispe IN, Owen MJ, Wen L, Hayday AC, Craft J: Murine lupus in the absence of αβ T cells. J Immunol 1996, 156:4041-4049.
16. Ma J, Xu J, Madaio MP, Peng Q, Zhang J, Grewal IS, Flavell RA, Craft J: Autoimmune Ipr/Ipr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J Immunol 1996, 157:417-426.
17. Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993, 177:1367-1381.
18. Burlingame RW, Boey ML, Starkebaum G, Rubin RL: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994, 94:184-192.
19. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK: Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995, 95:531-541. Several helper T cell lines established from patients with SLE and providing help to anti-DNA producing B cells were shown to respond to peptides derived from chromosomal proteins in the context of MHC class II.
20. Kaliyaperumal A, Mohan C, Wu W, Datta SK: Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 1996, 183:2459-2469.
21. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
22. Casciola-Rosen LA, Anhalt G, Rosen A: DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995, 182:1625-1634. Multiple SLE autoantigens are specifically cleaved during apoptosis, with autoimmune sera recognizing both the intact protein and cleavage products.
23. Casciola-Rosen L, Rosen A, Petri M, Schlissel M: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996, 93:1624-1629.
24. Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS: Antiphospholipid autoantibodies bind to apoptotic, but not nonapoptotic, thymocytes in a β2-glycoprotein I-dependent manner. J Immunol 1996, 157:2201-2208. APLs bound specifically to apoptotic, but not viable, thymocytes. Binding was dependent upon the presence of β2GPI, which interacted selectively with apoptotic thymocytes and thereby generated an epitope for aPLs.
25. Gilligan HM, Bredy B, Brady HM, Hébert M-J, Slayter HS, Xu Y, Rauch J, Shia MA, Koh JS, Levine JS: Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996, 184:2231-2241.
26. •], in which multiple SLE autoantigens were shown to be specifically cleaved during apoptosis.
27. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996, 183:1957-1964.
28. Madaio MP, Fabbi M, Tiso M, Daga A, Puccetti A: Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol 1996, 26:3035-3041.
29. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC: Studies of the lamin protease reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 1995, 92:9042-9046.
30. Savill J, Fadok V, Henson P, Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993, 14:131-136.
31. Sambrano GR, Steinberg D: Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 1995, 92:1396-1400.
32. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D: The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 1995, 92:9580-9584.
33. Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach J-F: Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol 1996, 26:472-486.
34. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S: Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vivo. Proc Natl Acad Sci USA 1996, 93:12456-12460.
35. Abraham R, Singh N, Mukhopadhvay A, Basu SK, Bal V, Rath S: Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J Immunol 1995, 154:1-8.
36. Vidard L, Kovacsovics-Bankowski M, Kraeft S-K, Chen LB, Benacerraf B, Rock KL: Analysis of MHC class II presentation of particulate antigens by B lymphocytes. J Immunol 1996, 156:2809-2818.
37. Hörkkö S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996, 98:815-825.
38. 1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum 1995, 38:1382-1388.
39. Yahya MD, Pinnas JL, Meinke GC, Lung C-C: Antibodies against malondialdehyde (MDA) in MRL/Ipr/Ipr mice: evidence for an autoimmune mechanism involving lipid peroxidation. J Autoimmun 1996, 9:3-9.
40. Kappler JW, Roehm N, Marrack PC: T cell tolerance by clonal elimination in the thymus. Cell 1987, 149:273-280.
41. + and abnormal Ipr and gld cell populations. J Exp Med 1989, 170: 1869-1877.
42. Scott DE, Kisch WJ, Steinberg AD: Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 1993, 150:664-672.
43. Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL: Selection of the T cell receptor repertoire in Ipr mice. J Immunol 1993, 151:3450-3459.
44. Rathmell JC, Goodnow CC: Effects of the Ipr mutation on elimination and inactivation of self-reactive B cells. J Immunol 1994, 153:2831-2842.
45. Rubio CF, Kench J, Russell DM, Yawger R, Nemazee D: Analysis of central B cell tolerance in autoimmune-prone MRL/Ipr mice bearing autoantibody transgenes. J Immunol 1996, 157:65-71.
46. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994, 1:365-371.
47. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC: Expansion or elimination of B cells in vivo: dual Roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996, 87:319-329.
48. Hannum LG, Ni D, Haberman AM, Weigert MG, Shlomchik MJ: A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med 1996, 184:1269-1278.
49. Ray SK, Putterman C, Diamond B: Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci USA 1996, 93:2019-2024.
50. Dalum I, Jensen MR, Hindersson P, Elsner HI, Mouritsen S: Breaking of B cell tolerance toward a highly conserved self protein. J Immunol 1996, 157:4796-4804.
51. Mamula MJ, Fatenejed S, Craft J: B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994, 152:1453-1461.
52. James JA, Gross T, Scofield RH, Harley JB: Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995, 181:453-461. Rabbits immunized with a single octapeptide from Sm B/B′ spliceosome polypeptide over time developed autoantibodies to all other components of the spliceosome.
53. Topper F, Gordon T, McCluskey J: Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci U S A 1995, 92:875-879. An elegant study examining both intermolecular and intramolecular antibody spreading in response to immunization with single components of the Ro/La ribonucleoprotein complex.
54. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB: Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1996, 156:4059-4066.
55. Keech CL, Gordon TP, McCluskey J: The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 1996, 157:3694-3699.
56. Reynolds P, Gordon TP, Purcell AW, Jackson DC, McCluskey J: Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J Exp Med 1996, 184:1857-1870.
57. Lou Y-H, McElveen MF, Garza KM, Tung KSK: Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance. J Immunol 1996, 156:3535-3540.
58. Mühlen CA, Tan EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995, 24:323-358.
59. Maddison, PJ, Reichlin M: Quantitation of precipitating antibodies to certain soluble nuclear antigens in systemic lupus erythematosus: their contribution to hyperglobulinemia. Arthritis Rheum 1977, 20:819-824.
60. Reichlin M, Martin A, Taylor-Albert E, Tsuzaka K, Zhang W, Reichlin MW, Koren E, Ebling FM, Tsao B, Hahn BH: Lupus autoantibodies to native DNA cross-react with the A and D snRNP polypeptides. J Clin Invest 1994, 93:443-449.
61. Zhang W, Reichlin M: IgM anti-A and D snRNP proteins and IgM anti-dsDNA are closely associated in SLE sera. Clin Immunol Immunopathol 1995, 74:70-76.
62. Tan EM: Antinuclear antibodies: diagnositic markers for autoimmune disease and probes for cell biology. Adv Immunol 1989, 44:93-151.
63. Herrman M, Winkler TH, Fehr H, Kalden JR: Preferential recognition of specific DNA motifs by anti-double-stranded DNA autoantibodies. Eur J Immunol 1995, 25:1897-1904.
64. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M: Antiribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995, 74:252-256.
65. Satoh M, Ajmani AK, Stojanov L, Langdon JJ, Ogasawara T, Wang J, Dooley MA, Richards HB, Winfield JB, Carter TH, Reeves WH: Autoantibodies that stabilize the molecular interaction of Ku antigen with DNA-dependent protein kinase catalytic subunit. Clin Exp Immunol 1996, 105:460-467.
66. Konstantinov K, Foisner R, Byrd D, Liu F-T, Tsai W-M, Wiik A, Gerace L: Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunopathol 1995, 74:88-99.
67. Kouts S, Wang M-X, Adelstein S, Krilis SA: Immunization of a rabbit with β2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies. J Immunol 1995, 155:958-966.
68. Wang M-X, Kandiah DA, Ichikawa K, Khamashta M, Hughes G, Koike T, Roubey R, Krilis SA: Epitope specificity of monoclonal anti-β2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 1995, 155:1629-1636.